Clinical trials recruiting for CDK4/6 Inhibitor
4
Recruiting trials
0
US states with sites
2
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 1Not applicable 3
Drugs and treatments being studied
Self-screener
Recruiting trials
- Breast Cancer RElapsed in Patients Treated With Adjuvant CDK4/6 Inhibitors:
- Efficacy and Safety of Dalpiciclib Combined With Endocrine Adjuvant Therapy for Early HR +/HER2- Breast Cancer: a Multicenter, Prospective Clinical Study
- Predicting clinicAL outcoMes During First-line CDK4/6 Inhibitors Plus Endocrine Therapy in Patients With Advanced Hormone REceptor-poSitive HER2-negative Breast Cancer: the Retrospective-prospective Multicenter Italian PALMARES-2 Study
- Safety Assessment of Concurrent Radiotherapy and Novel Systemic Therapy for Breast Cancer
Related conditions
Trials recruiting for CDK4/6 Inhibitor often also study these conditions. Each links to its own recruiting-trial list.
Breast cancer 2239HR+/HER2- Breast Cancer 17Breast Neoplasms 105Breast Diseases 8Trastuzumab 3Radiotherapy; Complications 6Immune Checkpoint Inhibitor 8HR-positive, HER2-negative Advanced Breast Cancer 5Hormone Receptor Positive HER-2 Negative Breast Cancer 8Hormone Receptor Positive Breast Carcinoma 13
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for CDK4/6 Inhibitor trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.